Clinical Research Directory
Browse clinical research sites, groups, and studies.
Naloxone for In-Hospital Cardiac Arrest
Sponsor: Region Skane
Summary
The goal of this clinical trial is to learn if the drug naloxone in addition to cardiopulmonary resuscitation improves outcomes of in-hospital cardiac arrets. The main questions it aims to answer are: Does naloxone improve survival after the cardiac arrest? Does naloxone improve functional outcome in survivors of cardiac arrest? Does naloxone improve health related quality of life after the cardiac arrest? How common are adverse reactions to naloxone when administered during cardiopulmonary resuscitation. Researchers will compare naloxone to a placebo (a look-alike substance that contains no drug) to see if naloxone works during cardiac arrest.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
850
Start Date
2027-01-01
Completion Date
2031-07-01
Last Updated
2026-09-08
Healthy Volunteers
No
Conditions
Interventions
naloxone
2 mg naloxone administered intravenously or intraosseously
Placebo
0.9% saline administered intravenously or intraosseously